Postpartum Healthcare after Gestational Diabetes and Hypertension

Journal of Women's Health

Volumn 23, Issue 9, 2014, Pages 760-764

  Ehrenthal, Deborah B ^a,b   Maiden, Kristin ^a   Rogers, Stephanie ^a   Ball, Amy ^a  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT; PRESCRIPTION DRUG; GLUCOSE BLOOD LEVEL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; COHORT ANALYSIS; DELIVERY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH LITERACY; HEALTH SURVEY; HOSPITAL DISCHARGE; HUMAN; INSULIN TREATMENT; INTERVIEW; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICALLY UNINSURED; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL PERIOD; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PROSPECTIVE STUDY; PUERPERIUM; UNIVERSITY HOSPITAL; WOMEN'S HEALTH; AGE; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEALTH CARE SURVEY; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; MASS SCREENING; METABOLISM; POSTNATAL CARE; PREGNANCY; PROCEDURES; QUESTIONNAIRE;

AGE FACTORS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; INTERVIEWS AS TOPIC; MASS SCREENING; POSTNATAL CARE; POSTPARTUM PERIOD; PREGNANCY; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 84921691775     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2013.4688     Document Type: Article

References (37)

1. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: Opportunities for intervention and screening? BMJ 2002;325:157-160.
2. Rich-Edwards JW, McElrath TF, Karumanchi SA, Seely EW. Breathing life into the lifecourse approach: Pregnancy history and cardiovascular disease in women. Hypertension 2010;56:331-334.
3. Wagner SJ, Barac S, Garovic VD. Hypertensive pregnancy disorders: Current concepts. J Clin Hypertens (Greenwich) 2007;9:560-566.
4. Berends AL, de Groot CJ, Sijbrands EJ, et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 2008;51:1034-1041.
5. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-1868.
6. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet 2009;373:1773-1779.
7. Sibai BM, Caritis S, Hauth J. What we have learned about preeclampsia. Semin Perinatol 2003;27:239-246.
8. Selvaggi L, Loverro G, Schena FP, Manno C, Cagnazzo G. Long term follow-up of women with hypertension in pregnancy. Int J Gynaecol Obstet 1988;27:45-49.
9. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003;41:437-445.
10. Robbins CL, Dietz PM, Bombard J, Valderrama AL. Gestational hypertension: A neglected cardiovascular disease risk marker. Am J Obstet Gynecol 2010;204:336.e1-9.
11. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009;53:944-951.
12. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974.
13. Smith GN, Pudwell J, Walker M, Wen SW. Risk estimation of metabolic syndrome at one and three years after a pregnancy complicated by preeclampsia. J Obstet Gynecol Can 2012;34:836-841.
14. Hermes W, Franx A, van Pampus MG, et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study. A Am J Obstet Gynecol 2013; 208:474.e1-8.
15. Valdiviezo C, Garovic VD, Ouyang P. Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk. Clinical cardiology 2012;35:160-165.
16. Saade GR. Pregnancy as a window to future health. Obstet Gynecol 2009;114:958-960.
17. Roberts JM, Catov JM. Pregnancy is a screening test for later life cardiovascular disease: Now what? Research recommendations. Womens Health Issues 2012;22:e123-128.
18. Ehrenthal DB, Catov JM. Importance of engaging obstetrician/ gynecologists in cardiovascular disease prevention. Curr Opin Cardiol 2013;28:547-553.
19. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A guideline from the American heart Association. Circulation 2011;123:1243-1262.
20. Bentley-Lewis R, Levkoff S, Stuebe A, Seely EW. Gestational diabetes mellitus: Postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2008;4:552-558.
21. Keely E, Clark H, Karovitch A, Graham I. Screening for type 2 diabetes following gestational diabetes: family physician and patient perspectives. Can Fam Physician 2010; 56:558-563.
22. Russell MA, Phipps MG, Olson CL, Welch HG, Carpenter MW. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 2006;108:1456-1462.
23. Hunsberger ML, Donatelle RJ, Lindsay K, Rosenberg KD. Physician care patterns and adherence to postpartum glucose testing after gestational diabetes mellitus in Oregon. PLoS One 2012;7:e47052.
24. Clark HD, van Walraven C, Code C, Karovitch A, Keely E. Did publication of a clinical practice guideline recommendation to screen for type 2 diabetes in women with gestational diabetes change practice? Diabetes Care 2003;26:265-268.
25. Carson MP, Frank MI, Keely E. Original research: Postpartum testing rates among women with a history of gestational diabetes-systematic review. Prim Care Diabetes 2013;7:177-186.
26. Nijdam ME, Timmerman MR, Franx A, et al. Cardiovascular risk factor assessment after pre-eclampsia in primary care. BMC Fam Pract 2009;10:77.
27. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: Validity of a two-item depression screener. Med Care 2003;41:1284-1292.
28. Zimet GNWD, Sara G. Zimet, Gordon K. Farley. The multidimensional scale of perceived social support. J Pers Assess 1988;52:30-41.
29. Roberti JW, Harrington LN, Storch, EA. Further psychometric support for the 10-item version of the Perceived Stress Scale. JCC 2006;9:135-147.
30. Cohen S, Williamson, G. Perceived stress in a probability sample of the United States. In: Oskamp SSS, ed. The social psychology of health: Claremont Symposium on applied social psychology. Newbury Park, CA: Sage, 1988.
31. Berkman ND, Dewalt DA, Pignone MP, et al. Literacy and health outcomes. Evid Rep Technol Assess (Summ) 2004: 1-8.
32. Heidrich MB, Wenzel D, von Kaisenberg CS, Schippert C, von Versen-Hoynck FM. Preeclampsia and long-term risk of cardiovascular disease: What do obstetrician-gynecologists know? BMC Pregnancy Childbirth 2013;13:61.
33. Lewis BG, Halm EA, Marcus SM, Korenstein D, Federman AD. Preventive services use among women seen by gynecologists, general medical physicians, or both. Obstet Gynecol 2008;111:945-952.
34. Centers for Disease Control and Prevention. Prevalence of cholesterol screening and high blood cholesterol among adults-United States, 2005, 2007, and 2009. MMWR Morb Mortal Wkly Rep 2012;61:697-702.
35. Tovar A, Chasan-Taber L, Eggleston E, Oken E. Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev Chronic Dis 2011;8:A124.
36. Braveman P. What is health equity: And how does a lifecourse approach take us further toward it? Matern Child Health J 2013;18:366-372.
37. Ehrenthal DB, Nunez AE, O'Neill E, Robertson-James C, Addo SF, Stewart A. The role of the obstetrician/gynecologist in the prevention of cardiovascular disease in women. Womens Health Issues 2011;21:338-344.